News
Stay informed
Below you will find all the latest news on Andera Partners, its teams and its investments.
Life Sciences portfolio company Gamamabs signs an agreement with Exelixis
Andera Partners strengthens its presence in the DACH region
Internship offer – Infrastructure investment
Artios Pharma announces collaboration with Novartis
Andera creates its own foundation
Andera Partners announces the arrival of Noëlla de Bermingham as Chief Sustainability Officer
ReViral and LianBio Announce Exclusive Collaboration
Pusterla 1880 issues Sustainability-Linked Bonds to finance its growth
Our 5th area of activity: Andera Infra
MedLumics closes upsized EUR 18M financing round and appoints new Chairman
Andera strengthens governance and targets €4-5 billion in AUM by 2025
Andera MidCap sells Skill & You to IK Investment Partners
MMI appoints healthcare industry veteran Mark Toland as CEO
Andera MidCap invests in Pusterla 1880
AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial
Andera sells its Life Sciences’ portfolio company Arvelle Therapeutics
Inotrem’s COVID-19 Phase IIa Clinical Trial declared “National Priority Research” by the French gove…
Significant agreements with Chinese market leaders in our Life Sciences portfolio
Andera Partners renames all its activities
The Power of And
Medlumics lands a 14M€ new financing round
Reviral raises $44 million in Series C financing
T-knife completes €66m Series A financing
COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19
ActoMezz IV: a single closing at more than €500 million
BioDiscovery sells Corvidia to Novo Nordisk
Appointment of Michael H. Carrel as chairman of the Axonics board of directors.
Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…
Andera Partners welcomes Constance Jay and strengthens its Investor Relations
Dynacure Announces €50M ($55M) Series C Financing
AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI
Newsletter – 03/2020
Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…
2019: a new record year for Andera
Inotrem Announces Enrollment of First Patient in its Phase IIb Trial in the Treatment of Septic Shoc…
Winch invests in Auxiga
Hans Van de Velde – Senior Advisor Belgium
BioDiscovery invests in AgomAb Therapeutics
BioDiscovery co-leads $133 million Financing in AM-Pharma B.V.
The ORCA Group acquires Italian companies Angeloni and Impregnatex
ic20: Initiative Climate 2020
Winch invests in Spherea
Winch invests in the Belgian company Infra Group
ActoMezz invests in Tournus
Appointments and Recruitments
A syndicate of international investors finance Arvelle Therapeutics
Grey Wolf Therapeutics completes £10 million series A financing with Andera Partners and Canaan
NetCo welcomes IK among its shareholders, alongside Andera and the founding family
2018: an emblematic year for Andera Partners
Winch Capital 4: fundraising completed at €445 million
Crescendo Biologics announces early licensing by Takeda
Promising results for the lead program of Genkyotex (BioDiscovery 3) in a fibrotic orphan disease
Artios Pharma Announces $86 million (£65 million) Series B Financing
WINCH Capital 4: a first closing of €360m for Andera Partners mid-cap fund
BioDiscovery invests in Dynacure to advance lead program into clinical development
Renewed governance for Andera Partners
ENYO Pharma raises €40 million in Series B fundraising
TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimall…
GamaMabs Pharma to present at 2018 ASCO annual meeting results from the First-In-Human clinical stud…
Crescendo Biologics Ltd. raises $70 Million (€57 Million) in Series B financing
Andera Partners sponsors the carve-out of Conduent’s Off-Street Parking business in association with…
Corvidia Therapeutics Secures $60 Million in Series B Funding
EdRIP becomes ANDERA PARTNERS
Sorry, no results.